JP Patent

JP2025519705A — Ｊａｋ阻害剤の固体形態及びその調製プロセス

Assigned to Incyte Corp · Expires 2025-06-26 · 1y expired

What this patent protects

本開示は、ルキソリチニブ二水和物及びルキソリチニブ遊離塩基の固体形態、その調製プロセス、ならびにそれを含む組成物に関する。

USPTO Abstract

本開示は、ルキソリチニブ二水和物及びルキソリチニブ遊離塩基の固体形態、その調製プロセス、ならびにそれを含む組成物に関する。

Drugs covered by this patent

ruxolitinib-phosphate (RUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: JP2025519705A
Jurisdiction: JP
Classification: —
Expires: 2025-06-26
Drug substance claim: No
Drug product claim: No
Assignee: Incyte Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.